Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RGS12 | O14924 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.42 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | APAF1 | O14727 | 1/20 | 0.40 |
| ▸ | RAD52 | P43351 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | XBP1 | P17861 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26818042 | 0.87 | RGS12 (0.40) | RGS12CYP2D6CYP2C19CTDSP1KMT2A | |
| SCHEMBL26817886 | 0.85 | ALDH1A1 (0.39) | RGS12CYP2D6CYP2C19CTDSP1KMT2A | |
| SCHEMBL26817860 | 0.76 | ATM (0.47) | RGS12KMT2AAPAF1RAD52MEN1 | |
| SCHEMBL26817972 | 0.70 | ALDH1A1 (0.47) | RGS12CYP2D6CYP2C19CTDSP1KMT2A | |
| SCHEMBL26817828 | 0.69 | TDP1 (0.50) | CYP2D6CYP2C19HTTSMN1; SMN2 | |
| Iodide SCHEMBL4381718 | 0.69 | KMT2A (0.53) | RGS12CYP2D6CYP2C19CTDSP1KMT2A | |
| Bromide SCHEMBL4388009 | 0.69 | KMT2A (0.53) | RGS12CYP2D6CYP2C19CTDSP1KMT2A | |
| SCHEMBL2947574 | 0.69 | KMT2A (0.56) | RGS12CYP2D6CYP2C19CTDSP1KMT2A | |
| SCHEMBL29624504 | 0.69 | KMT2A (0.56) | RGS12CYP2D6CYP2C19CTDSP1KMT2A | |
| SCHEMBL13227444 | 0.68 | ALDH1A1 (0.54) | RGS12CYP2D6CYP2C19CTDSP1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230382946-A1 | POLYPEPTIDE OR PROTEIN DIRECTIONAL MODIFICATION METHOD BASED ON SULFHYDRYL-ALKENYL AZIDE COUPLING | Changzhou University (CN) | 2023-11-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230382946-A1 | POLYPEPTIDE OR PROTEIN DIRECTIONAL MODIFICATION METHOD BASED ON SULFHYDRYL-ALKENYL AZIDE COUPLING | PTMS, CBS, CHAMP1 | RGS12 1124/4885CYP2D6 3318/4885CYP2C19 2666/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.